Bioptic Inc.

As of June 30, 2026, Bioptic Inc. carries a market capitalization of 1.13B, placing it among publicly traded companies globally. Its enterprise value stands at 1.03B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Bioptic Inc. has 33.09M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Bioptic Inc. maintains a current ratio of 5.33, meaning it holds 5.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Bioptic Inc.'s stock has declined approximately 33.63% over the past 52 weeks. The 50-day moving average sits at 32.47, while the 200-day moving average is 37.23.

As of June 30, 2026, Bioptic Inc. holds 188.24M in cash and equivalents against 80.56M in total debt, resulting in a net debt position of -113.54M. Total book value stands at 438.42M, with working capital of 274.35M providing operational flexibility.

Bioptic Inc.'s most recent stock split took place on August 20, 2025 with a 10:11 split ratio.